Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Teng

Showing results (211-220 of 249) with videos related to

Pageof 25
Sort By:
Biological & Pharmaceutical Bulletin|August 2, 2008
Antiplatelet effect and selective binding to cyclooxygenase by molecular docking analysis of 3-alkylaminopropoxy-9,10-anthraquinone derivativesKim-Hong Gan, Chi-Huang Teng, Hsien-Cheng Lin, et al.
Plos One|August 23, 2012
Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivoChin-Yu Lai, An-Chi Tsai, Mei-Chuan Chen, et al.
European Journal of Medicinal Chemistry|August 13, 2014
Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activitySamir Mehndiratta, Yi-Ling Hsieh, Yi-Min Liu, et al.
Journal of Medicinal Chemistry|June 26, 2007
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agentsLinyi Wei, Qian Shi, Kenneth F Bastow, et al.
The Journal of Biological Chemistry|February 2, 2011
Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expressionChun-Han Chen, Po-Hsien Huang, Po-Chen Chu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancerKaren L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2008
Impact of activated vitamin D and race on survival among hemodialysis patientsMyles Wolf, Joseph Betancourt, Yuchiao Chang, et al.
The Journal of Biological Chemistry|December 17, 2009
CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulationAn-Chi Tsai, Shiow-Lin Pan, Hui-Lung Sun, et al.
Plos One|August 29, 2012
Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivoHan-Li Huang, Han-Lin Huang, Hsueh-Yun Lee, et al.
Scientific Reports|August 17, 2016
MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancerHan-Li Huang, Min-Wu Chao, Ya-Chi Li, et al.
Pageof 25

Showing results (211-220 of 249) with videos related to

Sort By:
Pageof 25
Biological & Pharmaceutical Bulletin|August 2, 2008
Antiplatelet effect and selective binding to cyclooxygenase by molecular docking analysis of 3-alkylaminopropoxy-9,10-anthraquinone derivativesKim-Hong Gan, Chi-Huang Teng, Hsien-Cheng Lin, et al.
Plos One|August 23, 2012
Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivoChin-Yu Lai, An-Chi Tsai, Mei-Chuan Chen, et al.
European Journal of Medicinal Chemistry|August 13, 2014
Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activitySamir Mehndiratta, Yi-Ling Hsieh, Yi-Min Liu, et al.
Journal of Medicinal Chemistry|June 26, 2007
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agentsLinyi Wei, Qian Shi, Kenneth F Bastow, et al.
The Journal of Biological Chemistry|February 2, 2011
Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expressionChun-Han Chen, Po-Hsien Huang, Po-Chen Chu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancerKaren L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2008
Impact of activated vitamin D and race on survival among hemodialysis patientsMyles Wolf, Joseph Betancourt, Yuchiao Chang, et al.
The Journal of Biological Chemistry|December 17, 2009
CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulationAn-Chi Tsai, Shiow-Lin Pan, Hui-Lung Sun, et al.
Plos One|August 29, 2012
Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivoHan-Li Huang, Han-Lin Huang, Hsueh-Yun Lee, et al.
Scientific Reports|August 17, 2016
MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancerHan-Li Huang, Min-Wu Chao, Ya-Chi Li, et al.
Pageof 25